William Hoos

President of H37

William (Willy) Hoos is an entrepreneur, executive, and venture leader in healthcare innovation. Among leading the H37 team, Willy serves as President for the Jaime Leandro Foundation for Therapeutic Cancer Vaccines, is Vice President of Strategy with xCures, is a venture partner at Pilot Mountain Ventures, as well as Founder and CEO of NQ Oncology. In addition, he advises medical diagnostic, device, pharmaceutical and patient advocate organizations globally on product development and market strategy. His past clients include OncoPlexDx (acquired by NantOmics), Pancreatic Cancer Action Network, Skyline Diagnostics BV and Vanda Pharmaceuticals.

Willy earned an MBA from Georgia Institute of Technology. He holds a BS Chemistry from Wake Forest University and MS Organic Chemistry from the University of California, Los Angeles.